First Time Loading...

Coloplast A/S
OTC:CLPBF

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
OTC:CLPBF
Watchlist
Price: 129.18 USD 0.99% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Coloplast A/S develops, manufactures, and markets medical products. [ Read More ]

The intrinsic value of one CLPBF stock under the Base Case scenario is 100.53 USD. Compared to the current market price of 129.18 USD, Coloplast A/S is Overvalued by 22%.

Key Points:
CLPBF Intrinsic Value
Base Case
100.53 USD
Overvaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Coloplast A/S

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CLPBF stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Coloplast A/S

Provide an overview of the primary business activities
of Coloplast A/S.

What unique competitive advantages
does Coloplast A/S hold over its rivals?

What risks and challenges
does Coloplast A/S face in the near future?

Summarize the latest earnings call
of Coloplast A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Coloplast A/S.

Provide P/S
for Coloplast A/S.

Provide P/E
for Coloplast A/S.

Provide P/OCF
for Coloplast A/S.

Provide P/FCFE
for Coloplast A/S.

Provide P/B
for Coloplast A/S.

Provide EV/S
for Coloplast A/S.

Provide EV/GP
for Coloplast A/S.

Provide EV/EBITDA
for Coloplast A/S.

Provide EV/EBIT
for Coloplast A/S.

Provide EV/OCF
for Coloplast A/S.

Provide EV/FCFF
for Coloplast A/S.

Provide EV/IC
for Coloplast A/S.

Show me price targets
for Coloplast A/S made by professional analysts.

What are the Revenue projections
for Coloplast A/S?

How accurate were the past Revenue estimates
for Coloplast A/S?

What are the Net Income projections
for Coloplast A/S?

How accurate were the past Net Income estimates
for Coloplast A/S?

What are the EPS projections
for Coloplast A/S?

How accurate were the past EPS estimates
for Coloplast A/S?

What are the EBIT projections
for Coloplast A/S?

How accurate were the past EBIT estimates
for Coloplast A/S?

Compare the revenue forecasts
for Coloplast A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Coloplast A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Coloplast A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Coloplast A/S compared to its peers.

Compare the P/E ratios
of Coloplast A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Coloplast A/S with its peers.

Analyze the financial leverage
of Coloplast A/S compared to its main competitors.

Show all profitability ratios
for Coloplast A/S.

Provide ROE
for Coloplast A/S.

Provide ROA
for Coloplast A/S.

Provide ROIC
for Coloplast A/S.

Provide ROCE
for Coloplast A/S.

Provide Gross Margin
for Coloplast A/S.

Provide Operating Margin
for Coloplast A/S.

Provide Net Margin
for Coloplast A/S.

Provide FCF Margin
for Coloplast A/S.

Show all solvency ratios
for Coloplast A/S.

Provide D/E Ratio
for Coloplast A/S.

Provide D/A Ratio
for Coloplast A/S.

Provide Interest Coverage Ratio
for Coloplast A/S.

Provide Altman Z-Score Ratio
for Coloplast A/S.

Provide Quick Ratio
for Coloplast A/S.

Provide Current Ratio
for Coloplast A/S.

Provide Cash Ratio
for Coloplast A/S.

What is the historical Revenue growth
over the last 5 years for Coloplast A/S?

What is the historical Net Income growth
over the last 5 years for Coloplast A/S?

What is the current Free Cash Flow
of Coloplast A/S?

Financials

Balance Sheet Decomposition
Coloplast A/S

Current Assets 10.1B
Cash & Short-Term Investments 916m
Receivables 5.2B
Other Current Assets 3.9B
Non-Current Assets 38.5B
Long-Term Investments 65m
PP&E 6.1B
Intangibles 31.4B
Other Non-Current Assets 944m
Current Liabilities 18.9B
Accounts Payable 1.2B
Accrued Liabilities 7m
Short-Term Debt 4.3B
Other Current Liabilities 13.4B
Non-Current Liabilities 14.5B
Long-Term Debt 12.2B
Other Non-Current Liabilities 2.3B
Efficiency

Earnings Waterfall
Coloplast A/S

Revenue
25B DKK
Cost of Revenue
-8.3B DKK
Gross Profit
16.7B DKK
Operating Expenses
-9.8B DKK
Operating Income
6.9B DKK
Other Expenses
-2B DKK
Net Income
4.9B DKK

Free Cash Flow Analysis
Coloplast A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

CLPBF Profitability Score
Profitability Due Diligence

Coloplast A/S's profitability score is 70/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
Positive Free Cash Flow
70/100
Profitability
Score

Coloplast A/S's profitability score is 70/100. The higher the profitability score, the more profitable the company is.

CLPBF Solvency Score
Solvency Due Diligence

Coloplast A/S's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Average D/E
Average Interest Coverage
46/100
Solvency
Score

Coloplast A/S's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CLPBF Price Targets Summary
Coloplast A/S

Wall Street analysts forecast CLPBF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLPBF is 131.82 USD with a low forecast of 99.56 USD and a high forecast of 188.52 USD.

Lowest
Price Target
99.56 USD
23% Downside
Average
Price Target
131.82 USD
2% Upside
Highest
Price Target
188.52 USD
46% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

COLO B Price
Coloplast A/S

1M 1M
-3%
6M 6M
+24%
1Y 1Y
-4%
3Y 3Y
-4%
5Y 5Y
+43%
10Y 10Y
+164%
Annual Price Range
906
52w Low
697.4
52w High
985.4697
Price Metrics
Average Annual Return 8.96%
Standard Deviation of Annual Returns 23.37%
Max Drawdown -39%
Shares Statistics
Market Capitalization 203.7B DKK
Shares Outstanding 224 824 825
Percentage of Shares Shorted
N/A

COLO B Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Coloplast A/S Logo
Coloplast A/S

Country

Denmark

Industry

Health Care

Market Cap

203.7B USD

Dividend Yield

2.36%

Description

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.

Contact

Humlebaek
Holtedam 1-3
+4549111111.0
https://www.coloplast.dk/

IPO

1983-01-01

Employees

12 500

Officers

President & CEO
Mr. Kristian Villumsen
Executive VP & CFO
Mr. Anders Lonning-Skovgaard
Executive Vice President of Global Operations
Mr. Allan Rasmussen
Executive Vice President of Innovation
Mr. Nicolai Buhl Andersen
Executive Vice President of Growth
Mr. Paul Marcun
Senior Controller & Employees Representative Director
Mr. Thomas Barfod
Show More
Vice President of Investor Relations
Ellen Bjurgert
Director of Corporate Communications
Dennis Kaysen
Senior Vice President of People & Culture
Dorthe Ronnau
Senior Vice President of Sales Europe
Mr. Alain Morvan
Show Less

See Also

Discover More
What is the Intrinsic Value of one CLPBF stock?

The intrinsic value of one CLPBF stock under the Base Case scenario is 100.53 USD.

Is CLPBF stock undervalued or overvalued?

Compared to the current market price of 129.18 USD, Coloplast A/S is Overvalued by 22%.